Lipotropic injections are inappropriate or require careful evaluation in patients with known allergies to any component, uncontrolled medical conditions, significant renal or hepatic impairment, B12-related disorders, or pregnancy and breastfeeding
Novel Therapies in the Treatment of Congenital Hyperinsulinism
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
Insulin is produced in the body when blood sugar levels are higher after eating, signalling to the body that its time to use up that glucose for energy
Women with polycystic ovary syndrome (PCOS) represent another group who may potentially benefit
and Mounjaros active ingredient, tirzepatide, was approved for weight loss in the form of Zepbound in 2023